Ambroxol Hydrochloride is a mucolytic agent that facilitates the clearance of mucus from the respiratory tract. It is commonly used in the treatment of respiratory diseases such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Ambroxol works by breaking down the structure of mucus, making it easier to expel. AMBROXOL is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications. Other identifiers such UNII 200168S0CL and QH6ZT6J071.
Ambroxol Hydrochloride is a mucolytic agent that facilitates the clearance of mucus from the respiratory tract. It is commonly used in the treatment of respiratory diseases such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). Ambroxol works by breaking down the structure of mucus, making it easier to expel. AMBROXOL is a small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications. Other identifiers such UNII 200168S0CL and QH6ZT6J071.
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Intermediates & Precursors
Included in Quote
Included in Quote
Included in Quote
Included in Quote
.7767eb0f.png)
Chemical Properties & Specifications
Used as an active ingredient in formulations for treating respiratory conditions by reducing mucus viscosity.
Incorporated into over-the-counter and prescription medications aimed at alleviating productive coughs.
Ambroxol Intermediates are used in the synthesis of Ambroxol Hydrochloride, a widely prescribed mucolytic agent for respiratory conditions such as bronchitis, asthma, and COPD.
Ambroxol acts by breaking down mucus in the lungs, reducing its viscosity, and enhancing mucus clearance to facilitate easier breathing.
High demand is observed in North America, Europe, and Southeast Asia, where Ambroxol is extensively used in respiratory treatments
Manufacturers must comply with pharmacopeial standards such as IP, BP, and USP, ensuring Good Manufacturing Practices (GMP) and regulatory approvals for pharmaceutical applications.
Yes, Ambroxol is commonly formulated with bronchodilators and antihistamines in multi-ingredient respiratory medications.
Yes, Ambroxol Intermediates comply with global standards, including REACH, USP, EP/BP, and GMP-certified manufacturing processes.
CAS No. : 79560-20-6
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description: N-((1E)-4-(3,4-dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenylidene)methanamine, commonly known as a ...
